Clinical outcomes of endovascular embolization for the treatment of Spinal ArterioVenous Malformations (AVMs)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071218457N1

Enrollment

Registered

2014-12-02

Start date

2014-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Arterio-Venous Malformation. Spinal cord

Interventions

?Endovascular embolization

after catheterization of the tumor feeder artery, Onyx will be injected throughout the catheter..

Treatment - Other

after catheterization of the tumor feeder artery, Onyx will be injected throughout the catheter.

Eligibility

Sex/Gender

All

Age

10 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with spinal AVMs diagnosis Exclusion criteria: Patients under 10 years; Previous surgery for the treatment of AVMs; Allergic reaction to contrast material

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Walking, Muscle force, Urinary incontinence. Timepoint: After 6 months. Method of measurement: Aminoff Logue scale.	—

Secondary

Measure	Time frame
Tumor size. Timepoint: 6 months. Method of measurement: Spinal MRI.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hossein Ghanaati

Medical Imaging Center, Imam Khomeini Hospital, Tehran University of Medical Sciences (TUMS)

ghanaati@yahoo.com+98 21 6119 2670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026